SlideShare a Scribd company logo
BY: DR MAHESH YADAV
FIRST YEAR
Definition
 HUS, is a disease characterized by :
 Microangiopathic Hemolytic anemia
 Renal insufficiency (Uremia)
 Low platelet count
 Common cause of community acquired acute cause
kidney injury in young children
 It predominantly, but not exclusively, affects children.
Types HUS
 Typical HUS
 Atypical HUS
 HUS due to Complement abnormalities
CLASSIFICATION OF HUS / TTP ACCORDING
TO ETIOPATHOGENESIS
Type of HUS / TTP Specific Cause
 Infection related Shiga toxin producing E.coli/Shigella
Pneumococcal infection
HIV Typical
Other viral or bacterial infections
• Complement factor abnormality Factor H deficiency
Factor I deficiency
• Miscellaneous Drugs Atypical
Malignancy
ETIOPATHOGENESIS
 Typical/Diarrhea associated/Shiga Toxin
associated HUS
 Enterohaemorrhagic E. coli
 Shigella dysenteriae type 1
 Rarely, HUS can occur with E. coli UTI
CONTI..
 The common serotype of E coli:0157:H7
 However, only about 10-15% patients with E. coli
0157:H7 infection will develop HUS
 Sources of infection are :
 Milk and animal products (incompletely cooked beef,
pork, poultry,lamb)
 Human feco-oral transmission
 Vegetables, salads and drinking water may be
contaminated by bacteria shed in animal wastes
Atypical/Non-Diarrhea Related HUS
 Pneumococcal HUS
 HUS due to Complement abnormalities
 Miscellaneous Causes of HUS
 Abnormalities in intracellular vitamin B12 metabolism
 HIV
 Systemic lupus erythromatosus
 Malignancies
 Radiation
 Certain drugs
Other infections associated with HUS
 Include viruses like :
 Influenza
 Cytomegalovirus
 Infectious mononucleosis
 Bacteria like:
 Streptococcii
 Salmonella
CONTI…
 The typical pathophysiology involves the shiga-toxin
binding to proteins on the surface of glomerular
endothelium and inactivating a metalloproteinase
called ADAMTS13, which is also involved in the closely
related TTP
CONTI..
 The arterioles and capillaries of the body become
obstructed by the resulting complexes of activated
platelets which have adhered to endothelium via large
multimeric vWF.
 The growing thrombi lodged in smaller vessels destroy
RBCs as they squeeze through the narrowed blood
vessels, forming schistocytes, or fragments of sheared
RBCs.
CONTI…
 The consumption of platelets as they adhere to the
thrombi lodged in the small vessels typically leads to
mild or moderate thrombocytopaenia
 However, in comparison to TTP, the kidneys tend to
be more severely affected in HUS, and the central
nervous system is less commonly affected
CLINICAL FEATURES
 The commonest clinical presentation of HUS is :
 Acute pallor
 Oliguria
 Diarrhea or dysentery
 It occurs commonly in children between 1-5 years
of age
 HUS develops about 5-10 days after onset of diarrhea
CONTI..
 Hematuria and hypertension are common.
 Complications of fluid overload may present with:
 Pulmonary edema
 Hypertensive encephalopathy
 Despite thrombocytopenia, bleeding manifestations
are rare
 Neurological symptoms like:
 Irritability
 Encephalopathy
 Seizures
INVESTIGATIONS
 CBC-Anaemia & Thrombocytopenia
 Peripheral blood smears-Schistocytes,Helmet cells,Burr cells
 Coomb’s test results negtive except with S.PEUMONIA-
associated with HUS
 LDH - Elevated
 Bilirubin and Aminitranferase level elevated
 Uric Acid ,Cr & BUN- Increased
 Reticulocyte count increases
 Hyponatraemia,Hyperkalemia,Hypephostaemia,Hypocalcaemia,
Acidosis
 Urine analysis
 Hemoglobinuria
 Hematuria
 Proteinuria
Schistocytes
Investigations to Identify Cause
 In patients with dirrhea, the identification of
pathogenic EHEC or Shigella is performed by:
 Stool culture
 Further serotyping by agglutination or enzyme
immunoassay
 Rarely HUS can occur with E. coli UTI:
 Urine cultures are indicated in non-diarrheal patients
Conti..
 CXR – Pulmonary congestion and odema , if indicated
 Abdomen USG or CT scan –if suspicious of intestinal
obstruction or perforation
 MRI HEAD – If CNS symtoms or mental changes
 Bacteriological cultures of body fluids are indicated in
suspected pneumococcal disease.
 Sputum
 CSF
 Blood
 Pus
Diagnosis
 Clinically, HUS can be very hard to distinguish from
TTP
 The laboratory features are almost identical, and not
every case of HUS is preceded by diarrhea
 HUS is characterized by the triad of:
 Hemolytic anemia
 Thrombocytopenia
 Acute renal failure
Cont…
 The only distinguishing feature is that in TTP fever and
neurological symptoms are often present, but this is not
always the case
 A pericardial friction rub can also sometimes be heard on
auscultation
 The two conditions are sometimes treated as a single entity
called TTP/HUS.
MANAGEMENT
 Supportive Therapy
 Antibiotics
 Plasma Therapy
 Miscellaneous
Supportive Therapy
 In all patients, supportive treatment is primary.
 Close clinical monitoring of :
 Fluid status
 Blood pressure
 Neurological
 Ventilatory parameters
 Blood levels of glucose, electrolytes, creatinine and
hemogram need frequent monitoring
CONTI..
 The use of antimotility therapy for diarrhea has been
associated with a higher risk of developing HUS
 With the onset of acute renal failure :
 Fluid restriction
 Diuretics
Antibiotics
 E. coli
 Shigellosis
 pneumococcal HUS
Plasma Therapy
 In aHUS due to :
 complement factor abnormality
 ADAMTS13 deficiency
 The replacement of the deficient factor with FFP
 Daily plasma infusions (10 to 20 mL/kg/day)
 Exchange of 1.5 times plasma volume ( 60 to 75
mL/kg/day) using FFP
Miscellaneous
 In infants with HUS associated with cobalamin
abnormalities:
 Treatment with hydroxycobalamin
 Oral betaine
 Folic acid
 Normalizes the metabolic abnormalities can help to
prevent further episodes.
CONTI..
 In patients with persistent ADAMTS13 antibodies and
poor response to plasma exchange:
 Immunosuppressive therapy with high dose
steroids/cyclophosphamide/ cyclosporin/rituximab
 Splenectomy
Prognosis
 With aggressive treatment, more than 90% survive the
acute phase.
 About 9% may develop end stage renal disease.
 About one-third of persons with HUS have abnormal
kidney function many years later, and a few require long-
term dialysis.
 Another 8% of persons with HUS have other lifelong
complications, such as :
 High blood pressure
 Seizures
 Blindness
 Paralysis
KEY MESSAGES
 Good sanitation and maintenance of food hygiene can
prevent diarrhea associated HUS.
 Supportive care with early dialysis support remains the
cornerstone of management.
 Non-infective atypical HUS should be treated rapidly
with plasma therapy.
 Efforts should be made to make an etiological
diagnosis in cases of atypical HUS as treatment and
prognosis is affected.
Case Senario
 A 3 year old male is brought to the ED by his mother
with a chief complaint of bloody diarrhea. He has had
no fever, ill contacts, or recent exposure to children
with diarrhea. He is noted to be pale. His family
attended a birthday party 7 days prior where the child
had consumed uncooked meat.
 Exam: VS T 37.7 F, P 150/min, RR 28min, BP 100/45, oxygen
saturation 100% in RA. Weight 17 kg . He is alert but fussy,
pale, and non-toxic appearing. His conjunctiva are pale. His
TMs are normal. He has no nasal flaring or palatal
petechiae. His oral mucosa is moist and his tongue is pale.
His neck is supple without adenopathy. His heart has a
regular rhythm with tachycardia and a grade II/VI vibratory
systolic ejection murmur at the left sternal border without
radiation. No heaves, lifts, thrills, rubs, or gallops are
present. His lungs are clear with good aeration. His
abdomen is flat, soft, and non-tender, with the liver edge
palpable 3cm below the RCM. The spleen is non-palpable.
His genitalia and anus are normal (no rectal prolapse). His
pulses and perfusion are good. There is no edema, rash, or
petechiae.
 Labs: CBC: WBC 16,000 with 56% segs, 12% bands, 27%
lymphs, 3% eos, 2% basos, hemoglobin 8 mg/dL,
hematocrit 24.6, platelet count 75,000; peripheral
smear shows schistocytes, helmet cells, and
polychromasia. Na 133, K 5.9, Cl 96, bicarbonate 16,
BUN 45, creatinine 1.3, glucose 145 mg/dL, Ca 7.8, PO4
7.1, uric acid 7.3, and LDH 300. Coagulation studies are
normal.
Hemolytic uremicsyndrome-121116000313-phpapp01

More Related Content

What's hot

Hemolytic uremic syndrome
Hemolytic uremic syndrome Hemolytic uremic syndrome
Hemolytic uremic syndrome
Rivindu Wickramanayake
 
Hemolytic Uremic Syndrome Induced AKI (From Pathogenesis to Bedside) - Dr. Gawad
Hemolytic Uremic Syndrome Induced AKI (From Pathogenesis to Bedside) - Dr. GawadHemolytic Uremic Syndrome Induced AKI (From Pathogenesis to Bedside) - Dr. Gawad
Hemolytic Uremic Syndrome Induced AKI (From Pathogenesis to Bedside) - Dr. Gawad
NephroTube - Dr.Gawad
 
Atypical Hemolytic Uremic Syndrome
Atypical Hemolytic Uremic SyndromeAtypical Hemolytic Uremic Syndrome
Atypical Hemolytic Uremic Syndrome
RaahavendharSugumar
 
HUS Seminar
HUS SeminarHUS Seminar
Haemolytic uraemic syndrome
Haemolytic uraemic syndromeHaemolytic uraemic syndrome
Haemolytic uraemic syndrome
anestezjolog
 
Henoch Schonlein Purpura
Henoch Schonlein PurpuraHenoch Schonlein Purpura
Henoch Schonlein Purpura
yellow_sunfire102
 
Hemolytic uremic syndrome
Hemolytic uremic syndrome Hemolytic uremic syndrome
Hemolytic uremic syndrome
Rivindu Wickramanayake
 
HEMOLYTIC UREMIC SYNDROME IN CHILDREN 2022 BY DR VIJITHA
HEMOLYTIC UREMIC SYNDROME IN CHILDREN 2022 BY DR VIJITHAHEMOLYTIC UREMIC SYNDROME IN CHILDREN 2022 BY DR VIJITHA
HEMOLYTIC UREMIC SYNDROME IN CHILDREN 2022 BY DR VIJITHA
Vijitha A S
 
HUS
HUSHUS
Hemolytic Uremic Syndrome: A Dangerous Complication of E. coli
Hemolytic Uremic Syndrome: A Dangerous Complication of E. coliHemolytic Uremic Syndrome: A Dangerous Complication of E. coli
Hemolytic Uremic Syndrome: A Dangerous Complication of E. coli
Bill Marler
 
Hemolytic uremic syndrome
Hemolytic uremic syndromeHemolytic uremic syndrome
Hemolytic uremic syndrome
Tbilisi State Medical University
 
Haemolytic uremic syndrome
Haemolytic uremic syndromeHaemolytic uremic syndrome
Haemolytic uremic syndrome
Virendra Hindustani
 
hemolytic uremic syndrome
hemolytic uremic syndromehemolytic uremic syndrome
hemolytic uremic syndrome
hoseni
 
Atypical Hemolytic uremic syndrome
Atypical Hemolytic uremic syndromeAtypical Hemolytic uremic syndrome
Atypical Hemolytic uremic syndrome
Dr Shami Bhagat
 
Hemolytic uremic syndrome
Hemolytic uremic syndromeHemolytic uremic syndrome
Hemolytic uremic syndrome
Ahmed Zuhry
 
Henoch Schonlein Purpura (2)
Henoch Schonlein Purpura (2)Henoch Schonlein Purpura (2)
Henoch Schonlein Purpura (2)
Dang Thanh Tuan
 
Atypical hus
Atypical hus   Atypical hus
Atypical hus
katejohnpunag
 
Henoch-Schönlein purpura (HSP)
Henoch-Schönlein purpura (HSP)Henoch-Schönlein purpura (HSP)
Henoch-Schönlein purpura (HSP)
Ahmed Ghany
 
Henoch schonlein purpura
Henoch schonlein purpuraHenoch schonlein purpura
Henoch schonlein purpura
CSN Vittal
 
Sindrome hemolítico urêmica
Sindrome hemolítico urêmicaSindrome hemolítico urêmica
Sindrome hemolítico urêmica
Antonio Souto
 

What's hot (20)

Hemolytic uremic syndrome
Hemolytic uremic syndrome Hemolytic uremic syndrome
Hemolytic uremic syndrome
 
Hemolytic Uremic Syndrome Induced AKI (From Pathogenesis to Bedside) - Dr. Gawad
Hemolytic Uremic Syndrome Induced AKI (From Pathogenesis to Bedside) - Dr. GawadHemolytic Uremic Syndrome Induced AKI (From Pathogenesis to Bedside) - Dr. Gawad
Hemolytic Uremic Syndrome Induced AKI (From Pathogenesis to Bedside) - Dr. Gawad
 
Atypical Hemolytic Uremic Syndrome
Atypical Hemolytic Uremic SyndromeAtypical Hemolytic Uremic Syndrome
Atypical Hemolytic Uremic Syndrome
 
HUS Seminar
HUS SeminarHUS Seminar
HUS Seminar
 
Haemolytic uraemic syndrome
Haemolytic uraemic syndromeHaemolytic uraemic syndrome
Haemolytic uraemic syndrome
 
Henoch Schonlein Purpura
Henoch Schonlein PurpuraHenoch Schonlein Purpura
Henoch Schonlein Purpura
 
Hemolytic uremic syndrome
Hemolytic uremic syndrome Hemolytic uremic syndrome
Hemolytic uremic syndrome
 
HEMOLYTIC UREMIC SYNDROME IN CHILDREN 2022 BY DR VIJITHA
HEMOLYTIC UREMIC SYNDROME IN CHILDREN 2022 BY DR VIJITHAHEMOLYTIC UREMIC SYNDROME IN CHILDREN 2022 BY DR VIJITHA
HEMOLYTIC UREMIC SYNDROME IN CHILDREN 2022 BY DR VIJITHA
 
HUS
HUSHUS
HUS
 
Hemolytic Uremic Syndrome: A Dangerous Complication of E. coli
Hemolytic Uremic Syndrome: A Dangerous Complication of E. coliHemolytic Uremic Syndrome: A Dangerous Complication of E. coli
Hemolytic Uremic Syndrome: A Dangerous Complication of E. coli
 
Hemolytic uremic syndrome
Hemolytic uremic syndromeHemolytic uremic syndrome
Hemolytic uremic syndrome
 
Haemolytic uremic syndrome
Haemolytic uremic syndromeHaemolytic uremic syndrome
Haemolytic uremic syndrome
 
hemolytic uremic syndrome
hemolytic uremic syndromehemolytic uremic syndrome
hemolytic uremic syndrome
 
Atypical Hemolytic uremic syndrome
Atypical Hemolytic uremic syndromeAtypical Hemolytic uremic syndrome
Atypical Hemolytic uremic syndrome
 
Hemolytic uremic syndrome
Hemolytic uremic syndromeHemolytic uremic syndrome
Hemolytic uremic syndrome
 
Henoch Schonlein Purpura (2)
Henoch Schonlein Purpura (2)Henoch Schonlein Purpura (2)
Henoch Schonlein Purpura (2)
 
Atypical hus
Atypical hus   Atypical hus
Atypical hus
 
Henoch-Schönlein purpura (HSP)
Henoch-Schönlein purpura (HSP)Henoch-Schönlein purpura (HSP)
Henoch-Schönlein purpura (HSP)
 
Henoch schonlein purpura
Henoch schonlein purpuraHenoch schonlein purpura
Henoch schonlein purpura
 
Sindrome hemolítico urêmica
Sindrome hemolítico urêmicaSindrome hemolítico urêmica
Sindrome hemolítico urêmica
 

Viewers also liked

Unidad educativa
Unidad educativaUnidad educativa
Unidad educativa
jhoneitor452
 
Philips Roermond Vendor Rating
Philips Roermond Vendor RatingPhilips Roermond Vendor Rating
Philips Roermond Vendor RatingMartin Krabbenborg
 
Alaa Updated 14.11.16
Alaa Updated 14.11.16Alaa Updated 14.11.16
Alaa Updated 14.11.16
Alaa Abbas
 
풀무원 서브브랜드 퓨레떼
풀무원 서브브랜드 퓨레떼풀무원 서브브랜드 퓨레떼
풀무원 서브브랜드 퓨레떼
jinaya77
 
Dr mahesh approach to cough
Dr mahesh   approach to coughDr mahesh   approach to cough
Dr mahesh approach to cough
Dr. Mahesh Yadav
 
5 1099296681842704387
5 10992966818427043875 1099296681842704387
5 1099296681842704387
Dr. Mahesh Yadav
 
Yπoδείγματα 6 -7 - 8
Yπoδείγματα 6 -7 - 8Yπoδείγματα 6 -7 - 8
Yπoδείγματα 6 -7 - 8
Panayotis Sofianopoulos
 

Viewers also liked (7)

Unidad educativa
Unidad educativaUnidad educativa
Unidad educativa
 
Philips Roermond Vendor Rating
Philips Roermond Vendor RatingPhilips Roermond Vendor Rating
Philips Roermond Vendor Rating
 
Alaa Updated 14.11.16
Alaa Updated 14.11.16Alaa Updated 14.11.16
Alaa Updated 14.11.16
 
풀무원 서브브랜드 퓨레떼
풀무원 서브브랜드 퓨레떼풀무원 서브브랜드 퓨레떼
풀무원 서브브랜드 퓨레떼
 
Dr mahesh approach to cough
Dr mahesh   approach to coughDr mahesh   approach to cough
Dr mahesh approach to cough
 
5 1099296681842704387
5 10992966818427043875 1099296681842704387
5 1099296681842704387
 
Yπoδείγματα 6 -7 - 8
Yπoδείγματα 6 -7 - 8Yπoδείγματα 6 -7 - 8
Yπoδείγματα 6 -7 - 8
 

Similar to Hemolytic uremicsyndrome-121116000313-phpapp01

hemolytic-uremicsyndrome-121116000313-phpapp01.pdf
hemolytic-uremicsyndrome-121116000313-phpapp01.pdfhemolytic-uremicsyndrome-121116000313-phpapp01.pdf
hemolytic-uremicsyndrome-121116000313-phpapp01.pdf
drmanzoor234
 
Cyanotic Spells
Cyanotic SpellsCyanotic Spells
Cyanotic Spells
PriscillaNathan
 
Disorders of liver
Disorders of liverDisorders of liver
Disorders of liver
Dhara Vyas
 
Henoch-schonlein purpura.ppt
Henoch-schonlein purpura.pptHenoch-schonlein purpura.ppt
Henoch-schonlein purpura.ppt
ShamiPokhrel2
 
2. Glomerulonephritis & hypertension in children 01.04.15 lecture.pptx
2. Glomerulonephritis & hypertension in children 01.04.15 lecture.pptx2. Glomerulonephritis & hypertension in children 01.04.15 lecture.pptx
2. Glomerulonephritis & hypertension in children 01.04.15 lecture.pptx
Ivwananjisikombe1
 
Renal Disorders.pptx
Renal Disorders.pptxRenal Disorders.pptx
Renal Disorders.pptx
Tashriiq_Ahmed
 
Derma Git.
Derma Git.Derma Git.
Derma Git.
Shaikhani.
 
Pediatrics 5th year, 9th lecture (Dr. Adnan)
Pediatrics 5th year, 9th lecture (Dr. Adnan)Pediatrics 5th year, 9th lecture (Dr. Adnan)
Pediatrics 5th year, 9th lecture (Dr. Adnan)
College of Medicine, Sulaymaniyah
 
pediatrics.Glomerulonephritis.(dr.adnan hamawandi)
pediatrics.Glomerulonephritis.(dr.adnan hamawandi)pediatrics.Glomerulonephritis.(dr.adnan hamawandi)
pediatrics.Glomerulonephritis.(dr.adnan hamawandi)
student
 
Immune Thrombocytopenia (ITP)
Immune Thrombocytopenia (ITP)Immune Thrombocytopenia (ITP)
Immune Thrombocytopenia (ITP)
Dr. Renesha Islam
 
Chronic Liver Disease in pediatric: a case presentation and discussion
Chronic Liver Disease in pediatric: a case presentation and discussionChronic Liver Disease in pediatric: a case presentation and discussion
Chronic Liver Disease in pediatric: a case presentation and discussion
Dr Abdalla M. Gamal
 
Hemophilias Case based study
Hemophilias Case based study Hemophilias Case based study
Hemophilias Case based study
Akshat Jain M.D.
 
ITP
ITPITP
HSP presentation
HSP presentationHSP presentation
HSP presentation
Jafar Assaggaf
 
05 SCD (1).ppt
05 SCD (1).ppt05 SCD (1).ppt
05 SCD (1).ppt
AllanIbnSuma
 
Hellp syndrome
Hellp syndromeHellp syndrome
Hellp syndrome
drmcbansal
 
DISORDERS OF LIVER, PANCREAS AND BILIARY TRACT
DISORDERS OF LIVER, PANCREAS AND BILIARY TRACTDISORDERS OF LIVER, PANCREAS AND BILIARY TRACT
DISORDERS OF LIVER, PANCREAS AND BILIARY TRACT
Andhrapradesh
 
Acute & chronic liver failure
Acute & chronic liver failureAcute & chronic liver failure
Acute & chronic liver failure
Felisters Bosibori
 
Acute Liver Failure
Acute Liver Failure Acute Liver Failure
Acute Liver Failure
Amlendra Yadav
 
Primary biliary cirrhosis associated with gallstone
Primary biliary cirrhosis associated with gallstonePrimary biliary cirrhosis associated with gallstone
Primary biliary cirrhosis associated with gallstone
MsK for drug correlation
 

Similar to Hemolytic uremicsyndrome-121116000313-phpapp01 (20)

hemolytic-uremicsyndrome-121116000313-phpapp01.pdf
hemolytic-uremicsyndrome-121116000313-phpapp01.pdfhemolytic-uremicsyndrome-121116000313-phpapp01.pdf
hemolytic-uremicsyndrome-121116000313-phpapp01.pdf
 
Cyanotic Spells
Cyanotic SpellsCyanotic Spells
Cyanotic Spells
 
Disorders of liver
Disorders of liverDisorders of liver
Disorders of liver
 
Henoch-schonlein purpura.ppt
Henoch-schonlein purpura.pptHenoch-schonlein purpura.ppt
Henoch-schonlein purpura.ppt
 
2. Glomerulonephritis & hypertension in children 01.04.15 lecture.pptx
2. Glomerulonephritis & hypertension in children 01.04.15 lecture.pptx2. Glomerulonephritis & hypertension in children 01.04.15 lecture.pptx
2. Glomerulonephritis & hypertension in children 01.04.15 lecture.pptx
 
Renal Disorders.pptx
Renal Disorders.pptxRenal Disorders.pptx
Renal Disorders.pptx
 
Derma Git.
Derma Git.Derma Git.
Derma Git.
 
Pediatrics 5th year, 9th lecture (Dr. Adnan)
Pediatrics 5th year, 9th lecture (Dr. Adnan)Pediatrics 5th year, 9th lecture (Dr. Adnan)
Pediatrics 5th year, 9th lecture (Dr. Adnan)
 
pediatrics.Glomerulonephritis.(dr.adnan hamawandi)
pediatrics.Glomerulonephritis.(dr.adnan hamawandi)pediatrics.Glomerulonephritis.(dr.adnan hamawandi)
pediatrics.Glomerulonephritis.(dr.adnan hamawandi)
 
Immune Thrombocytopenia (ITP)
Immune Thrombocytopenia (ITP)Immune Thrombocytopenia (ITP)
Immune Thrombocytopenia (ITP)
 
Chronic Liver Disease in pediatric: a case presentation and discussion
Chronic Liver Disease in pediatric: a case presentation and discussionChronic Liver Disease in pediatric: a case presentation and discussion
Chronic Liver Disease in pediatric: a case presentation and discussion
 
Hemophilias Case based study
Hemophilias Case based study Hemophilias Case based study
Hemophilias Case based study
 
ITP
ITPITP
ITP
 
HSP presentation
HSP presentationHSP presentation
HSP presentation
 
05 SCD (1).ppt
05 SCD (1).ppt05 SCD (1).ppt
05 SCD (1).ppt
 
Hellp syndrome
Hellp syndromeHellp syndrome
Hellp syndrome
 
DISORDERS OF LIVER, PANCREAS AND BILIARY TRACT
DISORDERS OF LIVER, PANCREAS AND BILIARY TRACTDISORDERS OF LIVER, PANCREAS AND BILIARY TRACT
DISORDERS OF LIVER, PANCREAS AND BILIARY TRACT
 
Acute & chronic liver failure
Acute & chronic liver failureAcute & chronic liver failure
Acute & chronic liver failure
 
Acute Liver Failure
Acute Liver Failure Acute Liver Failure
Acute Liver Failure
 
Primary biliary cirrhosis associated with gallstone
Primary biliary cirrhosis associated with gallstonePrimary biliary cirrhosis associated with gallstone
Primary biliary cirrhosis associated with gallstone
 

More from Dr. Mahesh Yadav

Approach to anemia
Approach to anemiaApproach to anemia
Approach to anemia
Dr. Mahesh Yadav
 
Feeding of low birth weight neonates
Feeding of low birth weight neonatesFeeding of low birth weight neonates
Feeding of low birth weight neonates
Dr. Mahesh Yadav
 
Pphn
PphnPphn
Development of heart and fetal circulation
Development of heart and fetal circulationDevelopment of heart and fetal circulation
Development of heart and fetal circulation
Dr. Mahesh Yadav
 
Dengue fever
Dengue feverDengue fever
Dengue fever
Dr. Mahesh Yadav
 
Gbs
GbsGbs
Doc 20170102-wa0007
Doc 20170102-wa0007Doc 20170102-wa0007
Doc 20170102-wa0007
Dr. Mahesh Yadav
 
5 1099296681842704390
5 10992966818427043905 1099296681842704390
5 1099296681842704390
Dr. Mahesh Yadav
 
5 1099296681842704389
5 10992966818427043895 1099296681842704389
5 1099296681842704389
Dr. Mahesh Yadav
 
5 1093438501069783057
5 10934385010697830575 1093438501069783057
5 1093438501069783057
Dr. Mahesh Yadav
 
COMMON DRUG AND PLANT POISIONING
COMMON DRUG AND PLANT POISIONING COMMON DRUG AND PLANT POISIONING
COMMON DRUG AND PLANT POISIONING
Dr. Mahesh Yadav
 
RENAL REPALCEMENT THERAPY
RENAL REPALCEMENT THERAPY RENAL REPALCEMENT THERAPY
RENAL REPALCEMENT THERAPY
Dr. Mahesh Yadav
 
MUSCULAR DYSTROPHIES
MUSCULAR DYSTROPHIES MUSCULAR DYSTROPHIES
MUSCULAR DYSTROPHIES
Dr. Mahesh Yadav
 
APPROACH TO HAEMATURIA
APPROACH TO HAEMATURIAAPPROACH TO HAEMATURIA
APPROACH TO HAEMATURIA
Dr. Mahesh Yadav
 
APPROACH TO HAEMATURIA
APPROACH TO HAEMATURIAAPPROACH TO HAEMATURIA
APPROACH TO HAEMATURIA
Dr. Mahesh Yadav
 
Dr mahesh approach to cough
Dr mahesh   approach to coughDr mahesh   approach to cough
Dr mahesh approach to cough
Dr. Mahesh Yadav
 
Iycf journal club
Iycf journal clubIycf journal club
Iycf journal club
Dr. Mahesh Yadav
 

More from Dr. Mahesh Yadav (17)

Approach to anemia
Approach to anemiaApproach to anemia
Approach to anemia
 
Feeding of low birth weight neonates
Feeding of low birth weight neonatesFeeding of low birth weight neonates
Feeding of low birth weight neonates
 
Pphn
PphnPphn
Pphn
 
Development of heart and fetal circulation
Development of heart and fetal circulationDevelopment of heart and fetal circulation
Development of heart and fetal circulation
 
Dengue fever
Dengue feverDengue fever
Dengue fever
 
Gbs
GbsGbs
Gbs
 
Doc 20170102-wa0007
Doc 20170102-wa0007Doc 20170102-wa0007
Doc 20170102-wa0007
 
5 1099296681842704390
5 10992966818427043905 1099296681842704390
5 1099296681842704390
 
5 1099296681842704389
5 10992966818427043895 1099296681842704389
5 1099296681842704389
 
5 1093438501069783057
5 10934385010697830575 1093438501069783057
5 1093438501069783057
 
COMMON DRUG AND PLANT POISIONING
COMMON DRUG AND PLANT POISIONING COMMON DRUG AND PLANT POISIONING
COMMON DRUG AND PLANT POISIONING
 
RENAL REPALCEMENT THERAPY
RENAL REPALCEMENT THERAPY RENAL REPALCEMENT THERAPY
RENAL REPALCEMENT THERAPY
 
MUSCULAR DYSTROPHIES
MUSCULAR DYSTROPHIES MUSCULAR DYSTROPHIES
MUSCULAR DYSTROPHIES
 
APPROACH TO HAEMATURIA
APPROACH TO HAEMATURIAAPPROACH TO HAEMATURIA
APPROACH TO HAEMATURIA
 
APPROACH TO HAEMATURIA
APPROACH TO HAEMATURIAAPPROACH TO HAEMATURIA
APPROACH TO HAEMATURIA
 
Dr mahesh approach to cough
Dr mahesh   approach to coughDr mahesh   approach to cough
Dr mahesh approach to cough
 
Iycf journal club
Iycf journal clubIycf journal club
Iycf journal club
 

Recently uploaded

Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 

Recently uploaded (20)

Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 

Hemolytic uremicsyndrome-121116000313-phpapp01

  • 1. BY: DR MAHESH YADAV FIRST YEAR
  • 2. Definition  HUS, is a disease characterized by :  Microangiopathic Hemolytic anemia  Renal insufficiency (Uremia)  Low platelet count  Common cause of community acquired acute cause kidney injury in young children  It predominantly, but not exclusively, affects children.
  • 3. Types HUS  Typical HUS  Atypical HUS  HUS due to Complement abnormalities
  • 4. CLASSIFICATION OF HUS / TTP ACCORDING TO ETIOPATHOGENESIS Type of HUS / TTP Specific Cause  Infection related Shiga toxin producing E.coli/Shigella Pneumococcal infection HIV Typical Other viral or bacterial infections • Complement factor abnormality Factor H deficiency Factor I deficiency • Miscellaneous Drugs Atypical Malignancy
  • 5. ETIOPATHOGENESIS  Typical/Diarrhea associated/Shiga Toxin associated HUS  Enterohaemorrhagic E. coli  Shigella dysenteriae type 1  Rarely, HUS can occur with E. coli UTI
  • 6. CONTI..  The common serotype of E coli:0157:H7  However, only about 10-15% patients with E. coli 0157:H7 infection will develop HUS  Sources of infection are :  Milk and animal products (incompletely cooked beef, pork, poultry,lamb)  Human feco-oral transmission  Vegetables, salads and drinking water may be contaminated by bacteria shed in animal wastes
  • 7. Atypical/Non-Diarrhea Related HUS  Pneumococcal HUS  HUS due to Complement abnormalities  Miscellaneous Causes of HUS  Abnormalities in intracellular vitamin B12 metabolism  HIV  Systemic lupus erythromatosus  Malignancies  Radiation  Certain drugs
  • 8. Other infections associated with HUS  Include viruses like :  Influenza  Cytomegalovirus  Infectious mononucleosis  Bacteria like:  Streptococcii  Salmonella
  • 9. CONTI…  The typical pathophysiology involves the shiga-toxin binding to proteins on the surface of glomerular endothelium and inactivating a metalloproteinase called ADAMTS13, which is also involved in the closely related TTP
  • 10. CONTI..  The arterioles and capillaries of the body become obstructed by the resulting complexes of activated platelets which have adhered to endothelium via large multimeric vWF.  The growing thrombi lodged in smaller vessels destroy RBCs as they squeeze through the narrowed blood vessels, forming schistocytes, or fragments of sheared RBCs.
  • 11. CONTI…  The consumption of platelets as they adhere to the thrombi lodged in the small vessels typically leads to mild or moderate thrombocytopaenia  However, in comparison to TTP, the kidneys tend to be more severely affected in HUS, and the central nervous system is less commonly affected
  • 12. CLINICAL FEATURES  The commonest clinical presentation of HUS is :  Acute pallor  Oliguria  Diarrhea or dysentery  It occurs commonly in children between 1-5 years of age  HUS develops about 5-10 days after onset of diarrhea
  • 13. CONTI..  Hematuria and hypertension are common.  Complications of fluid overload may present with:  Pulmonary edema  Hypertensive encephalopathy  Despite thrombocytopenia, bleeding manifestations are rare  Neurological symptoms like:  Irritability  Encephalopathy  Seizures
  • 14. INVESTIGATIONS  CBC-Anaemia & Thrombocytopenia  Peripheral blood smears-Schistocytes,Helmet cells,Burr cells  Coomb’s test results negtive except with S.PEUMONIA- associated with HUS  LDH - Elevated  Bilirubin and Aminitranferase level elevated  Uric Acid ,Cr & BUN- Increased  Reticulocyte count increases  Hyponatraemia,Hyperkalemia,Hypephostaemia,Hypocalcaemia, Acidosis  Urine analysis  Hemoglobinuria  Hematuria  Proteinuria
  • 16. Investigations to Identify Cause  In patients with dirrhea, the identification of pathogenic EHEC or Shigella is performed by:  Stool culture  Further serotyping by agglutination or enzyme immunoassay  Rarely HUS can occur with E. coli UTI:  Urine cultures are indicated in non-diarrheal patients
  • 17. Conti..  CXR – Pulmonary congestion and odema , if indicated  Abdomen USG or CT scan –if suspicious of intestinal obstruction or perforation  MRI HEAD – If CNS symtoms or mental changes  Bacteriological cultures of body fluids are indicated in suspected pneumococcal disease.  Sputum  CSF  Blood  Pus
  • 18. Diagnosis  Clinically, HUS can be very hard to distinguish from TTP  The laboratory features are almost identical, and not every case of HUS is preceded by diarrhea  HUS is characterized by the triad of:  Hemolytic anemia  Thrombocytopenia  Acute renal failure
  • 19. Cont…  The only distinguishing feature is that in TTP fever and neurological symptoms are often present, but this is not always the case  A pericardial friction rub can also sometimes be heard on auscultation  The two conditions are sometimes treated as a single entity called TTP/HUS.
  • 20. MANAGEMENT  Supportive Therapy  Antibiotics  Plasma Therapy  Miscellaneous
  • 21. Supportive Therapy  In all patients, supportive treatment is primary.  Close clinical monitoring of :  Fluid status  Blood pressure  Neurological  Ventilatory parameters  Blood levels of glucose, electrolytes, creatinine and hemogram need frequent monitoring
  • 22. CONTI..  The use of antimotility therapy for diarrhea has been associated with a higher risk of developing HUS  With the onset of acute renal failure :  Fluid restriction  Diuretics
  • 23. Antibiotics  E. coli  Shigellosis  pneumococcal HUS
  • 24. Plasma Therapy  In aHUS due to :  complement factor abnormality  ADAMTS13 deficiency  The replacement of the deficient factor with FFP  Daily plasma infusions (10 to 20 mL/kg/day)  Exchange of 1.5 times plasma volume ( 60 to 75 mL/kg/day) using FFP
  • 25. Miscellaneous  In infants with HUS associated with cobalamin abnormalities:  Treatment with hydroxycobalamin  Oral betaine  Folic acid  Normalizes the metabolic abnormalities can help to prevent further episodes.
  • 26. CONTI..  In patients with persistent ADAMTS13 antibodies and poor response to plasma exchange:  Immunosuppressive therapy with high dose steroids/cyclophosphamide/ cyclosporin/rituximab  Splenectomy
  • 27. Prognosis  With aggressive treatment, more than 90% survive the acute phase.  About 9% may develop end stage renal disease.  About one-third of persons with HUS have abnormal kidney function many years later, and a few require long- term dialysis.  Another 8% of persons with HUS have other lifelong complications, such as :  High blood pressure  Seizures  Blindness  Paralysis
  • 28.
  • 29. KEY MESSAGES  Good sanitation and maintenance of food hygiene can prevent diarrhea associated HUS.  Supportive care with early dialysis support remains the cornerstone of management.  Non-infective atypical HUS should be treated rapidly with plasma therapy.  Efforts should be made to make an etiological diagnosis in cases of atypical HUS as treatment and prognosis is affected.
  • 30. Case Senario  A 3 year old male is brought to the ED by his mother with a chief complaint of bloody diarrhea. He has had no fever, ill contacts, or recent exposure to children with diarrhea. He is noted to be pale. His family attended a birthday party 7 days prior where the child had consumed uncooked meat.
  • 31.  Exam: VS T 37.7 F, P 150/min, RR 28min, BP 100/45, oxygen saturation 100% in RA. Weight 17 kg . He is alert but fussy, pale, and non-toxic appearing. His conjunctiva are pale. His TMs are normal. He has no nasal flaring or palatal petechiae. His oral mucosa is moist and his tongue is pale. His neck is supple without adenopathy. His heart has a regular rhythm with tachycardia and a grade II/VI vibratory systolic ejection murmur at the left sternal border without radiation. No heaves, lifts, thrills, rubs, or gallops are present. His lungs are clear with good aeration. His abdomen is flat, soft, and non-tender, with the liver edge palpable 3cm below the RCM. The spleen is non-palpable. His genitalia and anus are normal (no rectal prolapse). His pulses and perfusion are good. There is no edema, rash, or petechiae.
  • 32.  Labs: CBC: WBC 16,000 with 56% segs, 12% bands, 27% lymphs, 3% eos, 2% basos, hemoglobin 8 mg/dL, hematocrit 24.6, platelet count 75,000; peripheral smear shows schistocytes, helmet cells, and polychromasia. Na 133, K 5.9, Cl 96, bicarbonate 16, BUN 45, creatinine 1.3, glucose 145 mg/dL, Ca 7.8, PO4 7.1, uric acid 7.3, and LDH 300. Coagulation studies are normal.